IPSC Laboratory for CNS Disease Modeling
1 – 10 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties
(
- Contribution to journal › Article
-
Mark
Canonical Bone Morphogenetic Protein Signaling Regulates Expression of Aquaporin-4 and Its Anchoring Complex in Mouse Astrocytes
(
- Contribution to journal › Article
- 2021
-
Mark
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
(
- Contribution to journal › Article
-
Mark
Generation of the human pluripotent stem-cell-derived astrocyte model with forebrain identity
(
- Contribution to journal › Article
-
Mark
TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
(
- Contribution to journal › Article
- 2020
-
Mark
Stem cell-based models to study cellular alterations in Parkinson’s Disease
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes
(
- Contribution to journal › Article
-
Mark
Human iPSC-Derived Hippocampal Spheroids : An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
(
- Contribution to journal › Article
-
Mark
Unique signatures of stress-induced senescent human astrocytes
(
- Contribution to journal › Article